Bioventix PLC
BVXP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £143,598 | £165,731 | £228,371 | £227,772 |
| - Cash | £5,079 | £5,142 | £5,999 | £5,505 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £138,519 | £160,589 | £222,372 | £222,266 |
| Revenue | £6,384 | £6,732 | £6,931 | £6,675 |
| % Growth | -5.2% | -2.9% | 3.8% | – |
| Gross Profit | £5,910 | £5,914 | £6,403 | £6,222 |
| % Margin | 92.6% | 87.8% | 92.4% | 93.2% |
| EBITDA | £4,951 | £4,940 | £5,404 | £5,217 |
| % Margin | 77.6% | 73.4% | 78% | 78.2% |
| Net Income | £3,812 | £3,772 | £4,073 | £4,024 |
| % Margin | 59.7% | 56% | 58.8% | 60.3% |
| EPS Diluted | 0.72 | 0.71 | 0.78 | 0.76 |
| % Growth | 1.4% | -9% | 2.6% | – |
| Operating Cash Flow | £3,520 | £3,704 | £4,054 | £4,400 |
| Capital Expenditures | £0 | -£19 | -£11 | -£5 |
| Free Cash Flow | £3,520 | £3,685 | £4,043 | £4,395 |